Alain J Gelibter

6PUBLICATIONS
81CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 12, 2025
TTF-1 Negativity Predicts Poor Outcomes in Advanced Non-Squamous NSCLC Also in the Immunotherapy Era: A Multicenter Cohort Study and Meta-Analysis.

Leonardo Brunetti, Valentina Santo, Alessandro Galletti

|Jul 29, 2023
Circulating Natural Killer Cells as Prognostic Value for Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Correlation with Sarcopenia.

Marta Tenuta, Carla Pandozzi, Francesca Sciarra

|May 01, 2023
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer.

Alessio Cortellini, Antonio D'Alessio, Siobhan Cleary

|Apr 28, 2023
Rheumatic Diseases Development in Patients Treated by Anti-PD1 Immune Checkpoint Inhibitors: A Single-Centre Descriptive Study.

Fulvia Ceccarelli, Francesco Natalucci, Licia Picciariello

|May 28, 2022
Renal Function Outcomes in Metastatic Non-Small-Cell Lung Carcinoma Patients Treated with Chemotherapy or Immune Checkpoint Inhibitors: An Unexpected Scenario.

Francesco Trevisani, Federico Di Marco, Matteo Floris

|Jan 04, 2022
Circulating CD137+ T Cells Correlate with Improved Response to Anti-PD1 Immunotherapy in Patients with Cancer.

Ilaria Grazia Zizzari, Alessandra Di Filippo, Andrea Botticelli

Pageof 1

Frequent Collaborators

2 joint publications

Paolo Marchetti

2 joint publications

Michele Ghidini

2 joint publications

Alessio Cirillo

1 joint publications

Ilaria Grazia Zizzari